Changes in human basophil mRNA profiles during treatment with omalizumab

ABSTRACT: Human basophils were purified from whole blood, pre-treatment (=v3) and mid-treatment (=v6) on omalizumab. In addition, basophils were isolated from non-treated, non-CSU subjects for a comparison of CSU vs. non-CSU.

ORGANISM(S): Homo sapiens

PROVIDER: GSE167882 | GEO | 2021/03/01

REPOSITORIES: GEO